Schwächeln die Impfstoffe, wenn Delta dominiert?
Die Paper zu dieser Podcast-Folge:
Ravinrad Gupta et al, Research Square (Preprint), 2021, "SARS-CoV-2 B.1.617.2 Delta variant emergence and vaccine breakthrough"
Emma Wall et al, Lancet, 2021, "AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC"
Aziz Sheikh et al, Lancet, 2021, "SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness"
Chris Davis et al, medRxiv, "Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination"
Anegla Choi et al, bioRxiv, 2021, "Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants"
Lingshu Wang et al, Science, 2021, "Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants"
Kommentare
Neuer Kommentar